Amphotropic but not atherotropic: another caveat for adenoviral gene therapy.

This publication has 18 references indexed in Scilit:

• Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.
  Proceedings of the National Academy of Sciences, 1995
• Local drug delivery for the prevention of restenosis. Fact, fancy, and future.
  Circulation, 1994
• Making Clinical Grade Gene Therapy Vectors
  Human Gene Therapy, 1994
• Smooth muscle cell expression of extracellular matrix genes after arterial injury.
  1994
• Expression and subcellular distribution of basic fibroblast growth factor are regulated during migration of endothelial cells.
  Circulation Research, 1994
• A novel gene delivery system using EGF receptor‐mediated endocytosis
  FEBS Letters, 1994
• Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• The advent of adenovirus. Gene therapy for cardiovascular disease.
  Circulation, 1993
• Na(+)-H+ exchange inhibitors decrease neointimal formation after rat carotid injury. Effects on smooth muscle cell migration and proliferation.
  Circulation Research, 1993
• Localization of Basic Fibroblast Growth Factor in Bovine Endothelial Cells: Immunohistochemical and Biochemical Studies
  Experimental Cell Research, 1993